Davis KAVentilator-associated pneumonia: a review. J Intensive Care Med.2006;21:211-226.
2.
Liberati A., D'Amico R., Pifferi S., Torri V., Brazzi L.Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care. Cochrane Database Syst Rev.2004: CD000022.
3.
van Saene Hkf , Silvestri L., de la Cal MA, Sarginson RESelective decontamination of the digestive tract reduces lower airway and bloodstream infection and mortality and prevents emergence of antimicrobial resistance. Microbes Infect.2006;8:953-954.
4.
Vandenbroucke-Grauls Cmj, Vandenbroucke JPEffect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet. 1991;338:859-862.
5.
Selective Decontamination of the Digestive Tract Trialists' Collaborative Group.Meta-analysis of randomized controlled trials of selective decontamination of the digestive tract. BMJ.1993;307:525-532.
6.
Kollef M.The role of selective digestive tract decontamination on mortality and respiratory tract infections: a meta-analysis. Chest. 1994;105:1101-1108.
7.
Heyland DK, Cook DJ, Jaeschke R., Griffith L., Lee HN, Guyatt GHSelective decontamination of the digestive tract: an overview. Chest. 1994;105:1221-1229.
8.
Hurley JCProphylaxis with enteral antibiotics in ventilated patients: selective decontamination or selective cross-infection?Antimicrob Agents Chemother.1995;39:941-947.
9.
D'Amico R., Pifferi S., Leonetti C., Torri V., Tinazzi A., Liberati A.Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomized controlled trials. BMJ.1998;316:1275-1285.
10.
Nathens AB, Marshall JCSelective decontamination of the digestive tract in surgical patients: systematic review of the evidence. Arch Surg.1999;134:170-176.
11.
Redman R., Ludington E., Crocker M., Wittes J., Bellm L., Carlet J., and the VAP AdvisoryGroup. Analysis of respiratory and non-respiratory infections in published trials of selective digestive decontamination. Intensive Care Med.2001;27(suppl 1):S128.
12.
Safdar N., Said A., Lucey MRThe role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis . Liver Transpl.2004;10:817-827.
13.
Silvestri L. , van Saene HKF, Milanese M., Gregori D.Impact of selective decontamination of the digestive tract on fungal carriage and infection: systematic review of randomized controlled trials. Intensive Care Med.2005;31:898-910.
14.
Silvestri L. , Milanese M., Durì D., Gregori D., Gullo A., van Saene HKF.Impact of SDD on bloodstream infections: a systematic review of randomized trials. Intensive Care Med.2005;31(suppl 1):S87.
15.
Brun-Buisson C., Legrand P., Rauss A., et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med.1989 ;110:873-881.
16.
de Jonge E. , Schultz MJ, Spanjaard L., Bossuyt Pmm, Vroom MB, Dankert J.Effects of selective decontamination of the digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomized trial. Lancet.2003;362: 1011-1016.
17.
Silvestri L. , van Saene HKF.Selective decontamination of the digestive tract does not increase resistance in critically ill patients: evidence from randomized controlled trials. Crit Care Med.2006; 34:2027-2030.
18.
Silvestri L. , Petros AJ, Viviani M., Rommes JH, van Saene HKF.Selective decontamination of the digestive tract and ventilator associated pneumonia (part 1). Respir Care. 2006;51:67-69.
19.
Heininger A. , Mayer E., Schwab F., Marschal M., Unertl K., Krueger WAEffects of long-term use of selective decontamination on antimicrobial resistance. Intensive Care Med.2006; 32:1569-1576.
20.
Silvestri L. , van Saene Hkf, de la Cal MA, Gullo A.Adult hospital and ventilator-associated pneumonia guidelines: eminence rather than evidence based. Am J Respir Crit Care Med.2006;173:131-133.
21.
Silvestri L. , Milanese M., Oblach L., et al. Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control.2002;30:391-399.
22.
de la Cal MA , Cerda E., van Saene HK, et al. Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/ surgical intensive care unit. J Hosp Infect.2004;56:175-183.
23.
Viviani M., van Saene Hkf, Dezzoni R., et al. Control of imported and acquired methicillin-resistant Staphylococcus aureus (MRSA) in mechanically ventilated patients: a dose response study of enteral vancomycin to reduce absolute carriage and infection. Anaesth Intensive Care.2005;33:361-372.
24.
Sanchez M., Mir N, Canton R, et al. The effect of topical vancomycin on acquisition, carriage and infection with methicillin-resistant Staphylococcus aureus in critically ill patients. A double-blind, randomized, placebo-controlled study. 37th Interscience Conference of Antimicrobial Agents and Chemotherapy , 1007, Toronto, Canada, Abstract J-119. Herndon, Va: ASM Press; 1997:310.
25.
Silvestri L. , van Saene HKF, Milanese M., et al. Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomized trial. Eur Respir J. 2004;23:921-926.
26.
Arnow PM, Carandang GR, Zabner R., Irwin MERandomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis.1996;22:997-1003.
27.
Hellinger WC , Yao JD, Alvarez S., et al. A randomized, prospective, double-blind evaluation of selective bowel decontamination in liver transplantation. Transplantation.2002;73:1904-1909.
28.
van Saene Hkf , Silvestri L., de la Cal MA, Zandstra DFSelective decontamination of the digestive tract and ventilator associated pneumonia (part 2). Respir Care.2006;51:72-75.